Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Clearside Biomedical Inc
CLSDCurrent price
1.16 USD
-0.01 USD (-0.85%)
Last closed
1.16 USD
Company
www.clearsidebio.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
64 281 164 USD
Yield for 12 month
+1.75 %
Week
Month
Year
CLSD
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. Clearside Biomedical, Inc. has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Address: 900 North Point Parkway, Alpharetta, GA, United States, 30005
Analytics
WallStreet Target Price
5.67 USDP/E ratio
–Dividend Yield
–Current Year
+1 327 000 USD
Last Year
+29 575 000 USD
Current Quarter
+859 000 USD
Last Quarter
+1 018 000 USD
Current Year
+1 123 000 USD
Last Year
+29 575 000 USD
Current Quarter
+717 000 USD
Last Quarter
+805 000 USD
Key Figures CLSD
1 year
3 years
5 years
10 years
EBITDA
-29 930 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-41.62 %
PEG Ratio
–
Return On Equity TTM
-1310.02 %
Wall Street Target Price
5.67 USD
Revenue TTM
2 211 000 USD
Book Value
-0.21 USD
Revenue Per Share TTM
0.036 USD
Dividend Share
–
Quarterly Revenue Growth YOY
222.9 %
Dividend Yield
–
Gross Profit TTM
1 123 000 USD
Earnings Share
-0.61 USD
Diluted Eps TTM
-0.61 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CLSD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CLSD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CLSD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
16.0015
Price Sales TTM
29.0733
Enterprise Value EBITDA
-1.2581
Price Book MRQ
3.927
Financials CLSD
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators CLSD
For 52 weeks
0.65 USD
1.85 USD
50 Day MA
0.89 USD
Shares Short Prior Month
290 630
200 Day MA
1.05 USD
Short Ratio
1.54
Shares Short
292 878
Short Percent
0.5 %
Google
Apple
Facebook